Shigella isolates of Nepal: Changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern

Kathmandu University Medical Journal

Volumn 5, Issue 17, 2007, Pages 32-37

  Kansakar, Palpasa ^a   Malla, S ^a   Ghimire, G R ^a  

^a National Public Health Laboratory   (Nepal)

Author keywords

Antimicrobial resistance; Dysentery; Shigella; Shigella dysenteriae type 1

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; GEOGRAPHY; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; SEROTYPE; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS;

EID: 41949119522     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Keusch GT, Bennish ML. Shigellosis: Recent progress, persisting problems and research issues. Pediatr Infect Dis J 1989;8:713-719.
2. Bennish M L, Harris J R, Wojtyniak B J, Struelens M. Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis 1990;160:500-6.
3. Bennish ML. Potentially lethal complications of shigellosis. Rev Infect Dis 1991;13 (suppl 4): S319-S324.
4. Sack D A., Lyke C, LaughlinC M and Suwanvanichkij V,Antimicrobial resistance in shigellosis, cholera and campylobacteriosis, A Background document for the WHO global strategy for containment of Antimicrobial Resistance, WHO/CDS/CSR/DRS/2001.8.
5. Pazhani GP, Sarkar B, Ramamurthy T et al. Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India. Antimicrob Agents Chemother 2004;48:681-84.
6. Pal SC, Sengupta PG, Sen D, Bhattacharya SK, Deb BC. Epidemic shigellosis due to Shield dysenteriae type 1 in South Asia. Indian J Med Res 1989;89:57-64.
7. Dutta S, Rajendran K, Roy S, Chatterjee A, Dutta P, Nair GB, et al. Shifting serotypes, plasmid profile analysis and antimicoribal resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000. Epidemiol Infect 2002;129:235-43.
8. Dutta S, Dutta D, Dutta P, Matsushita S, Bhattacharya SK, Yoshida S. Shigella dysenteriae serotype 1, Kolkata, India. Emerg Infect Dis [serial online] 2003 Nov [date cited]. Available from: URL: http://www.cdc.gov/ncidod/ EID/vol9no11/02-0652.htm
9. Naheed A, Kalluri P, Talukder KA et al. Fluoroquinoloneresistant Shigella dysenteriae type 1 in northeastern Bangladesh. Lancet Infect Dis 2004;4:607-08.
10. Canada communicable Disease Report: Emergence of Quinolone-Resistant Shigella Dysenteriae Type 1 in Canada, Volume 31-19 1 October 2005 available from URL:http:\Emergence of Shigella Quinolone-Resistant Shigella dysenteriae Type 1 in Canada.htm.
11. Tauxe RV. Antimicrobial resistance of Shigella isolates in the USA: The importance of international travelers. J Infect Dis 1990;162:1107-1111.
12. Haltalin KC. Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. J Pediatr 1967;70:970-981.
13. Nelson JD et al. Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA 1976;235:1239-1243.
14. Chang MJ . Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Pediatr 1977;59:726-729.
15. DuPont HL, Steele JH. Use of antimicrobial agents in animal feeds: Implications for human health. Rev Infect Dis 1987;9:447-460.
16. DuPont HL . Current problems in antimicrobial therapy for bacterial enteric infection. Am J Med 1987;82(suppl 4A):324-328.
17. Bennish ML, Salam MA. Rethinking options for the treatment of shigellosis. J Antimicrob Chemother 1992; 30:243-247.
18. Bennish ML ,. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistant to ampicillin, trimethoprimsulfamethoxazole, and nalidixic acid. Clin Infect Dis 1992;14:1055-1060.
19. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrhoeal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998 Feb; 26 (2): 341-5.
20. ICDDR,B Periodicals, Increasing Antibiotic Resistance of Shigella species , Health and Science Bulletin (English): 2(1) 2004.
21. Jesudason MV, Lalitha MK, Koshi G. Changes in incidence of shigella subgroups and their antibiotic susceptibility pattern in Vellore, South India. J Trop Med Hyg 1985;88:355-358.
22. Munshi MH ,. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet 1987;2:419-421.
23. Ashkenazi S et al. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 1995;39:819-823.